Wockhardt chief Habil Khorakiwala says that Indian generic company as a whole is a competitive industry in US and therefore there is no scope for government intervention there. Anmol Ganjoo of JM Financial says if drug prices come down then Indian pharma ... Money Control, 1 week ago
Wockhardt hits fresh 52-week low on warning letter to C P Pharma - Smart Investor, 1 month ago
Wockhardt hits 52-week low - Business Standard India, 2 months ago
3 images for "habil khorakiwala"
Wockhardt chairman Habil Khorakiwala The US Food and Drug Administration (USFDA) has issued a warning letter to Wockhardt for violating current good manufacturing practice norms, including its failure to ensure proper clothing for workers at its ...Smart Investor, 2 weeks ago KIIT University confers D. Litt. upon Dr. Habil Khorakiwala, Founder Chairman, Wockhardt Group OrissaDiary, 2 months ago FDA Issues Warning Letter To Wockhardt???s Ankleshwar Plant BioSpace, 1 week ago Wockhardt's Ankleshwar unit gets EU good manufacturing certificate The Freepress Journal, 2 weeks ago
More from: NDTV, NDTV...and 5 other sources
"India has to put much more human efforts in science research. Greatness does not come by taking life easy, it comes by hard work," he said. Lamenting that few Indian universities and institutes find a place in global ranking of institutions of ...Indian Express, 6 days ago
NTPC, L&T, Infosys, ONGC and ICICI Bank are top gainers while Lupin, Dr Reddy's Labs, Coal India, Sun Pharma and BHEL are losers in the Sensex. 13:00 Moneycontrol Bureau 1:45 pm European market: Bourses in Europe opened lower after President-elect ...Moneycontrol.com, 1 week ago
Benchmark indices maintained uptrend amid volatility in noon trade but broader markets continued to underperform. Banks, infra and select technology stocks gained while the selling continued in FMCG, healthcare and HDFC group stocks. 12:00 ...Moneycontrol.com, 1 week ago
In the afternoon trade, BSE Sensex rose 114.19 points to 27,254.6, while NSE Nifty was up 28.9 points at 8,409.55, crossing the 8,400-mark for the first time since November 11. Pharmaceutical shares extended losses continued to limit the gains in ...Financial Express, 1 week ago
15:21 IST New Delhi [India], Dec.17 ( ANI ): The need for creating jobs and work opportunities for Indian youth is imperative in view of the country's demographic profile.The task is highly challenging, especially when technology is increasingly ...Ani News, 1 month ago
The pharmaceutical industry did suffer some set back with sales declining about 10-12 percent since demonetisation. However, Habil F Khorakiwala, Founder, Chairman Group CEO of Wockhardt feels the impact will last only until January at the most as cash ...Money Control, 1 month ago
Image: Vikas Khot In 2000-01, the HIV/Aids threat had intensified across sub-Saharan Africa, affecting millions. To compound the problem, the medicines that could help treat the condition were prohibitively priced, making them unaffordable for the ...Forbes India, 1 month ago
Wockhardt Shares Fall After FDA Warning Letter on U.K. Factory The healthcare firm's shares fell as much as 4.7 percent after the Food and Drug Administration issued a warning letter against a U.K. subsidiary's drug manufacturing facility, and ...Bloomberg-Quint, 1 month ago Wockhardt Shares Fall After FDA Warning Letter on U.K. Factory Bloomberg, 1 month ago
on your WebpageAdd Widget >Get your members hooked!